Solana Co — Director's Dealing 2020

Oct 26, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: HELIUS MEDICAL TECHNOLOGIES, INC. (HSDT)
CIK: 0001610853
Period of Report: 2020-10-21

Reporting Person: ANDREEFF DANE (Director, Interim President and CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-10-21	Class A Common Stock	A	638182	$0.4619	Acquired	1420525	Indirect
2020-10-21	Class A Common Stock	A	134873	$0.4619	Acquired	300953	Indirect
2020-10-21	Class A Common Stock	A	371883	$0.4619	Acquired	815842	Indirect
2020-10-21	Class A Common Stock	A	37363	$0.4619	Acquired	58945	Indirect

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-10-21	Warrant (Right to Buy)	$0.4619	A	319091	Acquired	2023-10-26	Class A Common Stock (319091)	Indirect
2020-10-21	Warrant (Right to Buy)	$0.4619	A	67436	Acquired	2023-10-26	Class A Common Stock (67436)	Indirect
2020-10-21	Warrant (Right to Buy)	$0.4619	A	185941	Acquired	2023-10-26	Class A Common Stock (185941)	Indirect
2020-10-21	Warrant (Right to Buy)	$0.4619	A	18681	Acquired	2023-10-26	Class A Common Stock (18681)	Indirect

Holdings (Non-Derivative)

Security	Shares	Ownership
Class A Common Stock	20000	Direct

Footnotes

F1: The shares and warrants are held by Maple Leaf Partners, L.P. ("MLP"). The reporting person is the managing member of Maple Leaf Capital I, LLC ("Maple Leaf Capital"), the general partner of MLP and as such may be deemed to beneficially own the securities owned by MLP. The reporting person disclaims beneficial ownership over such shares except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of the reported shares for purposes of Section 16 or for any other purposes.

F2: The shares and warrants are held by Maple Leaf Partners I, L.P. ("MLP I"). The reporting person is the managing member of Maple Leaf Capital, the general partner of MLP I and as such may be deemed to beneficially own the securities held by MLP I. The reporting person disclaims beneficial ownership over such shares except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of the reported shares for purposes of Section 16 or for any other purposes.

F3: The shares and warrants are held by Maple Leaf Discovery I, L.P. ("MLD I"). The reporting person is the managing member of Maple Leaf Capital, the general partner of MLD I and as such may be deemed to beneficially own the securities held by MLD I. The reporting person disclaims beneficial ownership over such shares except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of the reported shares for purposes of Section 16 or for any other purposes.

F4: The shares and warrants are held by Maple Leaf Offshore Ltd.. ("MLO"). The reporting person is the managing member of Maple Leaf Capital, the general partner of MLO and as such may be deemed to beneficially own the securities held by MLO. The reporting person disclaims beneficial ownership over such shares except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of the reported shares for purposes of Section 16 or for any other purposes.

F5: Immediately exercisable.